Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019005

Expand all

BRETYLIUM TOSYLATE IN DEXTROSE 5% (BRETYLIUM TOSYLATE)
200MG/100ML
Marketing Status: Discontinued

Active Ingredient: BRETYLIUM TOSYLATE
Proprietary Name: BRETYLIUM TOSYLATE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019005
Product Number: 002
Approval Date: Apr 29, 1986
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status:  Discontinued
Patent and Exclusivity Information

BRETYLIUM TOSYLATE IN DEXTROSE 5% (BRETYLIUM TOSYLATE)
400MG/100ML
Marketing Status: Discontinued

Active Ingredient: BRETYLIUM TOSYLATE
Proprietary Name: BRETYLIUM TOSYLATE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 400MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019005
Product Number: 003
Approval Date: Apr 29, 1986
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status:  Discontinued
Patent and Exclusivity Information

BRETYLIUM TOSYLATE IN DEXTROSE 5% (BRETYLIUM TOSYLATE)
800MG/100ML
Marketing Status: Discontinued

Active Ingredient: BRETYLIUM TOSYLATE
Proprietary Name: BRETYLIUM TOSYLATE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 800MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019005
Product Number: 001
Approval Date: Apr 29, 1986
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status:  Discontinued
Patent and Exclusivity Information